Icecure Accounts Payable vs Non Current Assets Total Analysis
ICCM Stock | USD 0.71 0.11 18.33% |
Icecure Medical financial indicator trend analysis is infinitely more than just investigating Icecure Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Icecure Medical is a good investment. Please check the relationship between Icecure Medical Accounts Payable and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
Accounts Payable vs Non Current Assets Total
Accounts Payable vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Icecure Medical Accounts Payable account and Non Current Assets Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Icecure Medical's Accounts Payable and Non Current Assets Total is 0.74. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Icecure Medical, assuming nothing else is changed. The correlation between historical values of Icecure Medical's Accounts Payable and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Icecure Medical are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Accounts Payable i.e., Icecure Medical's Accounts Payable and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.74 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Icecure Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Icecure Medical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from Icecure Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Icecure Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.As of the 24th of November 2024, Sales General And Administrative To Revenue is likely to grow to 1.56, while Selling General Administrative is likely to drop about 2.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 11.9M | 18.2M | 16.9M | 17.7M | Cost Of Revenue | 1.9M | 1.6M | 1.9M | 1.1M |
Icecure Medical fundamental ratios Correlations
Click cells to compare fundamentals
Icecure Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Icecure Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 13.6M | 17.1M | 28.5M | 37.0M | 45.6M | 47.9M | |
Total Assets | 7.3M | 10.3M | 32.3M | 30.2M | 16.4M | 12.7M | |
Other Current Liab | 1.1M | 3.1M | 2.0M | 2.8M | 3.0M | 1.8M | |
Total Current Liabilities | 3.6M | 3.9M | 4.0M | 4.3M | 3.9M | 2.7M | |
Total Stockholder Equity | 2.6M | 4.6M | 27.0M | 25.4M | 12.2M | 9.1M | |
Property Plant And Equipment Net | 377.4K | 621.7K | 1.6M | 2.0M | 2.2M | 2.3M | |
Net Debt | (5.5M) | (3.2M) | (24.7M) | (23.1M) | (9.9M) | (10.4M) | |
Retained Earnings | (48.5M) | (57.0M) | (58.4M) | (75.4M) | (90.1M) | (85.6M) | |
Accounts Payable | 425.7K | 645K | 881K | 714K | 502K | 452.6K | |
Cash | 5.8M | 3.5M | 25.6M | 23.7M | 10.5M | 9.3M | |
Non Current Assets Total | 417.6K | 658.4K | 2.0M | 2.1M | 2.2M | 2.3M | |
Non Currrent Assets Other | 19.9K | 36.7K | 333K | 34K | 39.1K | 67.8K | |
Cash And Short Term Investments | 5.8M | 3.5M | 25.6M | 23.7M | 11.1M | 9.4M | |
Net Receivables | 104.8K | 165K | 771K | 366K | 103K | 108.2K | |
Liabilities And Stockholders Equity | 7.3M | 10.3M | 32.3M | 30.2M | 16.4M | 12.7M | |
Non Current Liabilities Total | 1.1M | 1.8M | 1.3M | 430K | 376K | 357.2K | |
Inventory | 717.3K | 1.1M | 2.0M | 2.9M | 2.3M | 1.2M | |
Other Current Assets | 301.1K | 5.0M | 2.0M | 1.2M | 965K | 1.4M | |
Other Stockholder Equity | 45.4M | 62.6M | 85.4M | 100.8M | 102.2M | 62.7M | |
Total Liab | 4.7M | 5.8M | 5.3M | 4.8M | 4.2M | 3.6M | |
Total Current Assets | 6.9M | 9.7M | 30.3M | 28.1M | 14.2M | 11.8M | |
Common Stock | 1.3M | 2.7M | 3.5M | 5.0M | 5.8M | 6.1M | |
Other Assets | 139K | 118K | 333K | 34K | 39.1K | 37.1K | |
Other Liab | 2.7M | 3.3M | 5.7M | 618K | 556.2K | 528.4K | |
Net Tangible Assets | 9.1M | 14.7M | 27.0M | 25.4M | 29.2M | 16.1M | |
Net Invested Capital | 9.1M | 14.7M | 27.0M | 25.4M | 12.2M | 16.3M | |
Non Current Liabilities Other | 2.7M | 2.1M | 759K | 618K | 556.2K | 528.4K | |
Net Working Capital | 11.3M | 18.6M | 26.3M | 23.8M | 10.3M | 16.7M | |
Property Plant Equipment | 1.3M | 2.0M | 1.6M | 2.0M | 2.3M | 1.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.